Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Solid Malignancies × Fulvestrant × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Breast Neoplasms 292 Neoplasm Metastasis 36 Neoplasms 21 Ovarian Neoplasms 18 Advanced Breast Cancer 17 Endometrial Neoplasms 11 Prostatic Neoplasms 10 Carcinoma, Non-Small-Cell Lung 10 Hereditary Sensory and Autonomic Neuropathies 8 Triple Negative Breast Neoplasms 5 Multiple Endocrine Neoplasia Type 1 5 Breast Diseases 5 Breast Cancer Metastatic 5 Uterine Cervical Neoplasms 4 Squamous Cell Carcinoma of Head and Neck 4 Recurrence 4 Neoplasms by Site 4 Colorectal Neoplasms 4 Carcinoma, Ovarian Epithelial 4 Small Cell Lung Carcinoma 3 Pancreatic Neoplasms 3 Lung Neoplasms 3 Head and Neck Neoplasms 3 Fallopian Tube Neoplasms 3 Stomach Neoplasms 2 Melanoma 2 Lymphoma, Non-Hodgkin 2 Lymphoma 2 Liposarcoma 2 Hyperglycemia 2

Interventions

tremelimumab 1 ixabepilone 1 durvalumab 1 ST 1481 1 Paclitaxel 1 Fulvestrant 1 Docetaxel 1 Axitinib 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02640755 2019-04-22

14C

AstraZeneca

Phase 1 Completed

4 enrolled 34 charts

Solid Malignancies

Data powered by HemOnc (CC BY 4.0) Colophon ⚡